REQUEST A QUOTE
REQUEST A QUOTE

Google Search

Search

Already a Member ?

Register Now!

Best Business Opportunities in Uganda, Africa - Identification and Selection of right Project, Thrust areas for Investment, Industry Startup and Entrepreneurship Projects

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 21 of 63 | Total 630 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 21 62 63   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Tungsten Carbide Rod

Tungsten carbide (WC) is an inorganic chemical compound containing equal parts of tungsten and carbon atoms. In its most basic form, it is a fine gray powder, but it can be pressed and formed into shapes for use in industrial machinery, tools, abrasives, as well as. Tungsten carbide is approximately three times stiffer than steel, and is much denser than steel or titanium. It is comparable with corundum in hardness and can only be polished and finished with abrasives of superior hardness such as silicon carbide, cubic boron nitride. Tungsten Carbide Hard Metals are primarily produced using a Powder Metallurgy process, whereby the powdered forms of tungsten carbide and cobalt are mixed using ball mills, a binder material is added to hold the powders together during the next stage of the process which is compaction or pressing During the compaction processes, hydraulic presses or isotactic presses are used to compact the powders into a shape which approximates the design of the finished product. The chemical formula for Tungsten Carbide is WC. Tungsten carbide rods are manufactured without holes, with one straight hole, with double straight holes, with 30-degree spiral holes etc. The tungsten carbide rods polished or blank are used as solid drilling tools. They come with a diameter from 0.3mm to diameter 40.mm with lengths from 10mm to 1000mm and they are either grounded or ungrounded. The applications of these rods include as drill bits, end mills and reamers. They come in the straight or twisted and are available in standard lengths of 310 and 330 mm. In India, investments of USD 31,650 billion has been proposed by 99 cities under their smart cities plan. 100 smart cities and 500 cities are likely to invite investments worth INR 2 trillion in the next 5 years. Housing for All” program, launched in June 2015 aims to build 20 million urban homes and 30 million rural houses by 2022. Around 60 million new homes are expected to be built in India “between” 2018-2024. Thus, the growing manufacturing activities are instrumental for the growth of cemented carbide which in turn, boosting the market for tungsten carbide during the forecast period. The market for tungsten carbide is anticipated to grow at a moderate CAGR of over 3.5% during the forecast period. Growth in the manufacturing activities across the globe is generating demand for tungsten carbide. Tungsten carbide is highly dense material constituting of tungsten and carbide. This alloy is resistant to heat, rust, scratches, and pitting. The growth of tungsten carbide market can be attributed to its growing consumption in the applications such as machine & cutting tool components, dies & punches, abrasive products and others. The growing industrialization, and urbanization in the developing regions throughout the globe is expected to boost the market during the forecast years. The global market of tungsten carbide is a lucrative one and it is expected to expand at an encouraging CAGR during the forecast years. The excellent durability, high tensile strength, and corrosion & abrasion resistance of tungsten carbide makes it ideal to be used in mining & construction and automobile which is a major factor driving the market positively. Few Indian major players are as under Creative Tools & Press Components Pvt. Ltd. Rapicut Carbides Ltd Rashtriya Metal Inds. Ltd. Riddhi Steel & Tube Ltd. Ceratizit India Pvt. Ltd. V W F Industries Ltd. Taegutec India Pvt. Ltd.
Plant capacity: Tungsten Carbide Rod : 2 MT / DayPlant & machinery: Rs 119 lakhs
Working capital: -T.C.I: Cost of Project : Rs 607 lakhs
Return: 31.00%Break even: 59.00%
Add to Inquiry Add to Inquiry Basket

Active Pharma Ingredients • Azithromycin • Cefixime • Telmisartan • Diclofenac sodium • Acecloflenac

Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. The Active Pharmaceutical Ingredient (API) is the part of any drug that produces the intended effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways. Active pharmaceutical ingredient (API), is the term used to refer to the biologically active component of a drug product (e.g. tablet, capsule). Drug products are usually composed of several components. The aforementioned API is the primary ingredient. Other ingredients are commonly known as "excipients" and these substances are always required to be biologically safe, often making up a variable fraction of the drug product. The procedure for optimizing and compositing this mixture of components used in the drug is known as "formulation." The global active pharmaceutical ingredient market size is expected to reach a value of USD 286.6 billion by 2027, registering a CAGR of 6.7% over the forecast period. Factors, such as increasing preference for outsourcing APIs and growing prevalence of various target diseases such as cancer and Cardiovascular Diseases (CVDs) are expected to drive the market growth. The Asia Pacific is expected to emerge as the fastest-growing regional market due to rapidly increasing the prevalence of therapeutic and chronic diseases i.e., diabetes, cancer etc. with rising population in this region. According to WHO, around 65% of all cancer deaths occur in developing countries and the number of global cancer deaths is projected to increase by 45 percent from 2007 to 2030 with from 7.9 million to 11.5 million deaths influenced by rise in consumption of tobacco use, unhealthy diet, insufficient physical activity and the harmful use of alcohol in this region. The active pharmaceutical ingredients market gets a major boost from the growing prevalence of cardiovascular conditions, infectious diseases, and various other chronic disorders. Other than these, the rise in various genetic disorders has driven the use of biologicals and biosimilars, the world over. In many instances, biosimilars are the most preferred owing to them being low-cost. Biosimilars have the potential of creating a highly sustainable healthcare system which makes way for innovation, allowing more patients to receive the optimum care. Thus, due to demand it is best to invest in this project. Few Indian major players are as under Alpha Remedies Ltd. Ankur Drugs & Pharma Ltd. Aurobindo Pharma Ltd. Farmson Pharmaceutical Gujarat Pvt. Ltd. Glaxosmithkline Pharmaceuticals Ltd. Sanofi India Ltd. Piramal Enterprises Ltd. Teva Pharmaceutical & Chemical Inds. India Pvt. Ltd.
Plant capacity: Azithromycin: 500 Kgs / Day Cefixime: 500 Kgs / Day Telmisartan: 50 Kgs / Day Diclofenac Sodium: 500 Kgs / Day Aceclofenac: 500 Kgs / DayPlant & machinery: Rs 155 lakhs
Working capital: -T.C.I: Cost of Project : Rs 729 lakhs
Return: 31.00%Break even: 61.00%
Add to Inquiry Add to Inquiry Basket

Active Pharma Ingredients • Azithromycin • Cefixime • Telmisartan • Diclofenac sodium • Acecloflenac

Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. The Active Pharmaceutical Ingredient (API) is the part of any drug that produces the intended effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways. Active pharmaceutical ingredient (API), is the term used to refer to the biologically active component of a drug product (e.g. tablet, capsule). Drug products are usually composed of several components. The aforementioned API is the primary ingredient. Other ingredients are commonly known as "excipients" and these substances are always required to be biologically safe, often making up a variable fraction of the drug product. The procedure for optimizing and compositing this mixture of components used in the drug is known as "formulation." The global active pharmaceutical ingredient market size is expected to reach a value of USD 286.6 billion by 2027, registering a CAGR of 6.7% over the forecast period. Factors, such as increasing preference for outsourcing APIs and growing prevalence of various target diseases such as cancer and Cardiovascular Diseases (CVDs) are expected to drive the market growth. The Asia Pacific is expected to emerge as the fastest-growing regional market due to rapidly increasing the prevalence of therapeutic and chronic diseases i.e., diabetes, cancer etc. with rising population in this region. According to WHO, around 65% of all cancer deaths occur in developing countries and the number of global cancer deaths is projected to increase by 45 percent from 2007 to 2030 with from 7.9 million to 11.5 million deaths influenced by rise in consumption of tobacco use, unhealthy diet, insufficient physical activity and the harmful use of alcohol in this region. The active pharmaceutical ingredients market gets a major boost from the growing prevalence of cardiovascular conditions, infectious diseases, and various other chronic disorders. Other than these, the rise in various genetic disorders has driven the use of biologicals and biosimilars, the world over. In many instances, biosimilars are the most preferred owing to them being low-cost. Biosimilars have the potential of creating a highly sustainable healthcare system which makes way for innovation, allowing more patients to receive the optimum care. Thus, due to demand it is best to invest in this project. Few Indian major players are as under Alpha Remedies Ltd. Ankur Drugs & Pharma Ltd. Aurobindo Pharma Ltd. Farmson Pharmaceutical Gujarat Pvt. Ltd. Glaxosmithkline Pharmaceuticals Ltd. Sanofi India Ltd. Piramal Enterprises Ltd. Teva Pharmaceutical & Chemical Inds. India Pvt. Ltd.
Plant capacity: Azithromycin: 500 Kgs / Day Cefixime: 500 Kgs / Day Telmisartan: 50 Kgs / Day Diclofenac Sodium: 500 Kgs / Day Aceclofenac: 500 Kgs / DayPlant & machinery: Rs 155 lakhs
Working capital: -T.C.I: Cost of Project : Rs 729 lakhs
Return: 31.00%Break even: 61.00%
Add to Inquiry Add to Inquiry Basket

Copper Wire Manufacturing (Wire Drawing & Enamalling)

Copper is easily stretched, molded, and shaped; is resistant to corrosion; and conducts heat and electricity efficiently. As a result, copper was important to early humans and continues to be a material of choice for a variety of domestic, industrial, and high-technology applications today. Presently, copper is used in building construction, power generation and transmission, electronic product manufacturing, and the production of industrial machinery and transportation vehicles. Copper wiring and plumbing are integral to the appliances, heating and cooling systems, and telecommunications links used every day in homes and businesses. Copper is an essential component in the motors, wiring, radiators, connectors, brakes, and bearings used in cars and trucks. Copper wire is used in power generation, power transmission, power distribution, telecommunications, electronics circuitry, and countless types of electrical equipment. Copper and its alloys are also used to make electrical contacts. Electrical wiring in buildings is the most important market for the copper industry. Copper wires have better thermal and electrical properties than other wires. Copper is about 25 per cent more conductive than others, accounting for better heat dissipation and increased power rating and a main factor to the development of high performance, high power and ?ne-pitch devices using smaller-diameter copper wire to accommodate smaller pad sizes. Higher electrical conductivity leads to less-heat generation and a higher speed. The growing demand for power, light and communication has kept a high demand for cables and wires, which constitute roughly 40% of India’s electrical industry. Wires and cables play a vital role in every aspect of infrastructural growth and finds extensive usage and applications across a number of industries. Wire and cables demand is directly dependent on the growth of the manufacturing industry and infrastructure in the power, telecommunications, residential and commercial sectors. Thus the government’s initiatives on various fronts like – power, housing, infrastructure and digitization are sure to generate a lot of business for the wire and cable industry in foreseeable future. The global winding wire market size was valued at USD 25.6 billion in 2018 and is expected to witness a revenue-based CAGR of 3.7% from 2019 to 2025. Rising demand for the product from the energy sector is the significant factor driving the market for winding wire. Entrepreneurs who invest in this project will be successful. Few Indian major players are as under Bharat Insulation Co. (India) Pvt. Ltd. Chandra Metals Pvt. Ltd. Grid India Power Cables Pvt. Ltd. Millennium Wires Pvt. Ltd. Rajasthan Electronics Ltd. Sagar Industries Ltd. Sumo Metallic Pvt. Ltd.
Plant capacity: Copper Wire (0.914 to 0.376 mm) : 350 Kgs / Day Enamelled Copper Wire (0.914 to 0.376 mm): 350 Kgs / Day Intermediate Copper Wire (2.5 mm): 4,000 Kgs / Day Intermediate Copper Wire (1.2 mm): 5,000 Kgs / DayPlant & machinery: Rs 437 lakhs
Working capital: -T.C.I: Cost of Project: Rs 951 lakhs
Return: 30.00%Break even: 52.00%
Add to Inquiry Add to Inquiry Basket

Lithium Ion Battery (Battery Assembly)

Lithium batteries are now powering a wide range of electrical and electronically devices, including laptop computers, mobile phones, power tools, telecommunication systems and new generations of electric cars and vehicles. Lithium metal batteries and lithium ion batteries. Basically, the difference between them is that lithium metal batteries are those that are not rechargeable, thus, primary, and lithium ion batteries are those that can be recharged. As an example, your laptop or cell phone is likely to have a lithium ion battery, whereas your watch may have a lithium metal battery. The India lithium-ion battery market is expected to grow at a robust CAGR of 29.26% during the forecast period, 2018-2023. The Indian automobile sector is one of the most prominent sectors of the country, accounting for nearly 7.1% of the national GDP. The industry produced a total of 25.31 million vehicles, including commercial, passenger, two, and three vehicles and commercial quadricycle in April-March 2017, as against 24.01 million in April-March 2016. However, India has set itself an ambitious target of having only electric vehicles (EV) by 2030, which is expected to increase the demand for lithium-ion batteries in India, significantly. “In the coming years, India is expected to witness substantial investments by various companies to set up their Li-ion battery manufacturing base in the country. Entrepreneurs who invest in this project will be successful. Few Indian major players are as under H B L Power Systems Ltd. Luminous Power Technologies Pvt. Ltd. Okaya Power Pvt. Ltd. Eon Electric Ltd. Carborundum Universal Ltd. Bharat Electronics Ltd.
Plant capacity: 48 Volt, 60 AH Lithium-Ion Battery Pack : 5 Nos / Day 48 Volt, 80 AH Lithium-Ion Battery Pack : 5 Nos / Day 48 Volt, 100 AH Lithium-Ion Battery Pack : 5 Nos / Day 60 Volt, 20 AH Lithium-Ion Battery Pack : 5 Nos / Day 60 Volt, 30 AH Lithium-Ion Battery PacPlant & machinery: Rs 306 lakhs
Working capital: -T.C.I: Cost of Project : Rs 648 lakhs
Return: 28.00%Break even: 62.00%
Add to Inquiry Add to Inquiry Basket

Azithromycin, Cefixime, Telmisartan, Diclofenac Sodium, Acecloflenac Manufacturing. Production of Active Pharma Ingredients (API).

Azithromycin, Cefixime, Telmisartan, Diclofenac Sodium, Acecloflenac Manufacturing. Production of Active Pharma Ingredients (API). Opportunities for Entrepreneurs to Start Own Industry. The active pharmaceutical ingredient (API) is the part of any drug that produces the intended effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways. Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. Related Project: - Active Pharma Ingredients • Azithromycin • Cefixime • Telmisartan • Diclofenac Sodium • Acecloflenac Active Pharmaceutical Ingredient (API) is the portion of drug that generates intentional effects. APIs are biologically and chemically active constituents of medicines with direct effect in mitigation, prevention, cure and treatment of diseases. Some of the medicines like combination therapies have many active ingredients to treat diverse symptoms or perform in numerous ways. Active Pharmaceutical Ingredient has active ingredient that is contained in medicine. For illustration, an active ingredient to reduce pain is incorporated in a painkiller. A slight amount of the active ingredient has result thus only small part of the active ingredient is confined in medicine. Role of Government towards API The coronavirus outbreak disrupting supply of active pharmaceutical ingredients (APIs) and medical devices from China to India, the government has come out with four schemes worth Rs 13,760 crore to encourage manufacturing of bulk drugs and medical devices in the country and their exports. On March 21, the Union Cabinet under the chairmanship of Prime Minister Narendra Modi had approved an expenditure of Rs. 9,940 crore and Rs. 3,820 crore for APIs and medical devices, respectively. Related Videos: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs The Cabinet also approved a scheme on promotion of bulk drug parks for financing common infrastructure facilities in three bulk drug parks with financial implication of Rs. 3,000 crore for next five years. The government will give grants-in-aid to states with a maximum limit of Rs. 1,000 crore per bulk Drug Park. Parks will have common facilities such as solvent recovery plant, distillation plant, power and steam units, common effluent treatment plant etc. The government further approved production linked incentive (PLI) scheme for promotion of domestic manufacturing of critical KSMs/drug intermediates and APIs in the country with financial implications of Rs. 6,940 crore for next eight years. Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. Rate of incentive will be 20 per cent (of incremental sales value) for fermentation based bulk drugs and 10 per cent for chemical synthesis based bulk drugs. The PLI scheme will lead to expected incremental sales of Rs. 46,400 crore and significant additional employment generation over eight years. The drug industry has welcomed the incentives offered by the government to promote API units in India. Besides APIs, the Cabinet also approved the scheme for promotion of medical device parks in the country in partnership with the states. A maximum grant-in-aid of Rs. 100 crore per park will be provided to the states. It will have financial implications of Rs. 400 crore. The PLI scheme for promoting domestic manufacturing of medical devices will have financial implications of Rs. 3,420 crore for next five years. Medical device is a growing sector and its potential for growth is the highest among all sectors in the healthcare market. It is valued at Rs. 50,026 crore for 2018-19 and is expected to reach to Rs. 86,840 crore by 2021-22. India depends on imports up to an extent of 85 per cent of total domestic demand of medical devices. Union Cabinet scheme on Promotion of Bulk Drug Parks • The scheme on Promotion of Bulk Drug Parks for financing Common Infrastructure Facilities in 3 Bulk Drug Parks with financial implication of Rs. 3,000 crore for next five years. • Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical KSMs/Drug Intermediates and APIs in the country with financial implications of Rs6,940 crore for next eight years. Details: Promotion of Bulk Drug Parks • Decision is to develop 3 mega Bulk Drug parks in India in partnership with States. • Government of India will give Grants-in-Aid to States with a maximum limit of Rs. 1000 Crore per Bulk Drug Park. • Parks will have common facilities such as solvent recovery plant, distillation plant, power & steam units, common effluent treatment plant etc. • A sum of Rs. 3,000 crore has been approved for this scheme for next 5 years. Production Linked Incentive Scheme • Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. • Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. • Rate of incentive will be 20 % (of incremental sales value) for fermentation based bulk drugs and 10% for chemical synthesis based bulk drugs. • A sum of Rs. 6,940 crore has been approved for next 8 years. Market Outlook Active Pharmaceutical Ingredients Market Dynamics The growing cases of chronic diseases are one of the leading causes of hospitalization, and a majority of the patients with these conditions may need re-admission in hospitals due to infection leading to other chronic diseases. For instance, according to the report published by the Centers for Disease Control and Prevention (CDC), nearly 92.1 million adults in the US dealt with at least one type of cardiovascular disease in 2017. Besides, CDC has also stated that out of the total annual healthcare expenditure, i.e., USD 27 trillion, 86% is for the people with chronic health conditions in the US. Some of the prime factors spurring the growth of the market are increasing occurrences of cardiovascular, oncology, lifestyle and diabetes diseases, intensifying number of diagnostic centers and hospitals and escalating elderly population in emerging countries. Furthermore, cumulative healthcare spending, growing disease responsiveness and education are propelling the growth of the market. Related Projects: - Active Pharmaceutical Ingredient (API) Products, Bulk API Manufacturing With advancements in healthcare infrastructure, healthcare spending has increased over time. This augmenting focus on healthcare spending positively influences the market for active pharmaceutical ingredients. The high adoption rate of generic drugs in developed and developing economies is fueling the growth of the market. Another positive impact comes from the high demand for specialty medicines which is anticipated to escalate the spending in the pharmaceutical sector. Developed nations are expected to exhibit faster growth in these spending as compared to the developing economies on the back of factors such as the presence of adequate manufacturing units, transparent pricing, and higher spending power. Specialty medicines a trend in the active pharmaceutical ingredients market A higher generic adoption rate in developed countries that ranges from 27% to 32% is driving global medicine spending and aiding greater access to improved, lifesaving healthcare services. The adoption of branded generic drugs is predicted to be higher in emerging economies such as China and India and generic drugs accounted for nearly 80% of the total drugs sold by value in these fast-growing nations in 2016. Rising use of specialty medicines is anticipated to grow the pharmaceutical spending worldwide with quicker growth in richer, developed nations as compared to their emerging counterparts. This is primarily because the former have adequate manufacturing units, a higher spending power, and greater emphasis on transparent pricing by assessing measuring effects on the population. Related Books: - Pharmaceutical, Drugs, Proteins Technology Handbooks Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of a drug (e.g. tablet, capsule). A drug is usually composed of several components. The API represents the primary ingredient. Other ingredients are commonly known as "excipients. Sometimes a drug can contain several APIs and its effect on a patient depends on the dosage prescribed and can vary from person to person. In combination therapies, two or more than two active ingredients are used to treat different symptoms in different ways. Stringent quality control is a mandate when it comes to the manufacturing of drugs as the API represents the main component considered while making the prescription. The global active pharmaceutical ingredient market size is expected to reach a value of USD 286.6 billion by 2027, registering a CAGR of 6.7% over the forecast period. Factors, such as increasing preference for outsourcing APIs and growing prevalence of various target diseases such as cancer and Cardiovascular Diseases (CVDs) are expected to drive the market growth. Related Videos: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs The major factors driving the overall growth of the APIs market in this region include the growing incidence of preventable chronic diseases, increasing government focus on generic drugs, rising demand for biologics and specialty drugs, and technological advancements in the manufacturing processes of APIs. This market segment is expected to grow at a modest rate due to a combination of economic and healthcare severity measures and the introduction of low-cost, generic versions of branded drugs. Key Players:- Alpha Remedies Ltd. Ankur Drugs & Pharma Ltd. Aurobindo Pharma Ltd. Cian Healthcare Ltd Cipla Ltd. Dr. Reddy'S Laboratories Ltd. Farmson Pharmaceutical Gujarat Pvt. Ltd. Glaxosmithkline Pharmaceuticals Ltd. Indoco Remedies Ltd. Pan Drugs Ltd. Piramal Enterprises Ltd. Sanofi India Ltd. Sri Krishna Pharmaceuticals Ltd. Teva Pharmaceutical & Chemical Inds. India Pvt. Ltd. Triton Laboratories Ltd. Tags: - #APIBusiness #apimanufacturing #Apiproduction #APImarket #APIProject #ApiStartup #APIindustry #Activepharmaingredients #pharmaingredients #IndianPharma, #medicineingredients #CoronavirusBusiness #COVID2019 #Activepharmaingredientbusinessplan #APIbusinessplan #APIbusinessidea #startupAPIbusiness #Activepharmaingredientmanufacturing #APIproduction #API #Azithromycin #Cefixime #Telmisartan #Diclofenacsodium #Acecloflenac #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #entrepreneurindia #startupbusiness #startupbusinessideas #howtostartbusiness #InvestInStartups #Plan4Business #StartupProject #ProjectReport #startupplan #BusinessKaiseshurukare #BusinessProjectReport
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Manufacturing of Ciprofloxacin Hydrochloride (CIPRO) - Active Pharma Ingredient

Manufacturing of Ciprofloxacin Hydrochloride (CIPRO) - Active Pharma Ingredient. Investment Opportunity for Startups and Entrepreneurs. Ciprofloxacin is an antibiotic agent in the fluoroquinolone class used to treat bacterial infections such as urinary tract infections and pneumonia. Ciprofloxacin is FDA approved for the treatment of urinary tract infections, sexually transmitted infections (gonorrhea and cancroid), skin, bone and joint infections, prostatitis, typhoid fever, gastrointestinal infections, lower respiratory tract infections, anthrax, plague, and salmonellosis. Related Projects: - Active Pharmaceutical Ingredient (API) Products, Bulk API Manufacturing Uses and Applications Ciprofloxacin only treats bacterial infections; it does not treat viral infections such as the common cold. For certain uses including acute sinusitis, lower respiratory tract infections and uncomplicated gonorrhea, ciprofloxacin is not considered a first-line agent. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Mycoplasma contamination is a major problem in cell culture in biomedical and biopharmaceutical research, with rates near 15-30%. While there is no method for visual confirmation of mycoplasma, contamination has serious effects on key characteristics and functions of cells, thus compromising any research done. Cipro (ciprofloxacin hydrochloride) is the standard antibiotic for rapid and efficient decontamination. Related Books: - Pharmaceutical, Drugs, Proteins Technology Handbooks CIPRO is indicated in adult patients for treatment of complicated intra-abdominal infections (used in combination with metronidazole) caused by Escherichia coli, Pseudomonas aeruginosa, Proteus mirabilis, Klebsiella pneumoniae, or Bacteroides fragilis. Ciprofloxacin (Cetraxal, Ciloxan, and Cipro) is an inexpensive drug used to treat certain bacterial infections. It is more popular than comparable drugs. Application Urogenital Infections Respiratory Tract Infections Gastrointestinal Infections Typhoid Bone and Joint Infections Skin and Soft Tissue Infections Sepsis and Other Systemic Infections Related Videos: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs Government Initiatives • Some of the initiatives taken by the Government to promote the pharmaceutical sector in India are as follows: • India plans to set up a nearly Rs 1 lakh crore (US$ 1.3 billion) fund to provide boost to companies to manufacture pharmaceutical ingredients domestically by 2023. • In November 2019, the Cabinet approved extension/renewal of extant Pharmaceuticals Purchase Policy (PPP) with the same terms and conditions while adding one additional product namely, Alcoholic Hand Disinfectant (AHD) to the existing list of 103 medicines till the final closure/strategic disinvestment of Pharma CPSUs. • Under Budget 2020-21, Rs 65,012 crore (US$ 9.30 billion) has been allocated to the Ministry of Health and Family Welfare is. The Government has allocated Rs 34,115 crore (US$ 4.88 billion) towards the National Health Mission under which rural and urban people will get benefited. • Rs 6,400 crore (US$ 915.72 million) has been allocated to health insurance scheme Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY). • As per Economic Survey 2019-20, Government expenditure (as a percentage of GDP) increased to 1.6 per cent in FY20 from 1.2 per cent in FY15 on health. Related Projects: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates • The National Health Protection Scheme is the largest Government funded healthcare programme in the world, which is expected to benefit 100 million poor families in the country by providing a cover of up to Rs 5 lakh (US$ 7,723.2) per family per year for secondary and tertiary care hospitalisation. The programme was announced in Union Budget 2018-19. • The Government of India is planning to set up an electronic platform to regulate online pharmacies under a new policy to stop any misuse due to easy availability. • Government of India unveiled 'Pharma Vision 2020' to make India a global leader in end-to-end drug manufacture. Approval time for new facilities has been reduced to boost investment. • India has imposed a provisional anti-dumping duty on imports of Ciprofloxacin Hydrochloride from China on the grounds that it was hurting domestic industry, following an investigation of the Directorate General of Trade Remedies (DGTR). • The department of revenue issued a notification to the effect on September 2, imposing a duty ranging between $0.94 and $3.29 per kg coming from China. • Ciprofloxacin Hydrochloride is used to treat different types of bacterial infections and certain types of diarrhea. The DGTR had initiated the investigation in January this year. Related Videos: - Industrial, Medical and Specialty Gases Manufacturing Project Ideas Market Outlook The India ciprofloxacin market is segmented based on composition, source, and form, route of administration, distribution channel, application, end user, company and region. Based on route of administration, the market can be categorized into oral, ophthalmic, optic, and intravenous and others. The intravenous segment is expected to witness significant growth through FY2026. This can be ascribed to the use of this route of administration for the drugs which are not absorbed after consumption through oral route. Additionally, large quantities of drug can be administered using this route of drug administration with 100% bioavailability. The Global Ciprofloxacin Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2020 to 2027. Related Project:- Ciprofloxacin Hydrochloride Indian pharmaceutical sector is expected to grow to US$ 100 billion, while medical device market is expected to grow US$ 25 billion by 2025. Pharmaceuticals export from India stood at US$ 20.70 billion in FY20. Pharmaceutical export include bulk drugs, intermediates, drug formulations, biological, Ayush and herbal products and surgical. The remaining of the active pharmaceutical ingredient of ciprofloxacin is being dispersed in another combination product and specifically utilize in the urinary tract antibiotic only. Thereby anticipated to lure the new market players in the ciprofloxacin market. The higher incidence of skin and immunological disorder is anticipated to offer a steady revenue generation opportunity in the ciprofloxacin market. Increase awareness about safe drug utilization, however increase in adverse drug reaction awareness and stringent government impositions have narrowed the growth path for global Ciprofloxacin market in North America. Furthermore in East Asia region considerably higher market growth rate is expected due to higher utilization of ciprofloxacin in renal infection in the region. Thereby anticipated to increase the revenue generation in the Ciprofloxacin market. Related Projects: - Chemicals (Organic, Inorganic, Industrial) Projects The bulk drugs segment continues to be the highest revenue generating segment for the Indian pharma industry. It accounts for production worth Rs 120 bn and contributes about 36% of the total pharma exports. India produces 400 bulk drugs through its 1,300 licensed bulk drug units that cater to most of the domestic bulk drug requirements. Related Projects: - Active Pharma Ingredients(API) Key Players:- ? Aarti Drugs Ltd. ? Aurobindo Pharma Ltd. ? Cipla Ltd. ? Indoco Remedies Ltd. ? Kores (India) Ltd. ? Mylan Pharmaceuticals Pvt. Ltd. ? Neuland Laboratories Ltd. ? S S Organics Ltd ? Smruthi Organics Ltd. ? Sreepathi Pharmaceuticals Ltd. ? Sterling Basic Organics Ltd. ? Sun Pharma Laboratories Ltd. ? Sun Pharma Medisales Pvt. Ltd. ? Wockhardt Ltd. Tags:- #CiprofloxacinHydrochloride #Ciprofloxacin #CiprofloxacinBusinessPlan #activepharmaceuticalingrediants #activepharmaingredient #Pharmaceutical #pharmaindustry #APIManufacturing #APIProduction #APImarket #APIBusiness #APIbusinessplan #startupAPIbusiness #CIPRO #startyourbusiness #investmentopportunity #covidbusiness #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #bussinessplanshub #Startupbusiness4you #StartupBusinessPlan #startupinvestment #startup #ChemicalIndustry
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Automated Vehicle Scrapping and Recycling Unit

Automated Vehicle Scrapping and Recycling Unit What is Auto Shredding? The scrapping of cars and large household equipment is a method where the components fed into it are grinded to fist-size bits by a hammer mill. A combination of ferrous material, non-ferrous metal (e.g. copper and aluminium alloys), and shredding scrap, called vehicle shredder remnants of automotive shredder residue, resulted in the shredding of vehicles (ASR). ASR is made up of glass, fabric, rubber, liquids for vehicles, plastics, and soil. Often ASR is divided into dust and shredder in small proportion. These leftover materials are considered 'Car-fluff' occasionally. Related Projects: - Waste Management and Recycling At such a time when different economies run solely on recycled car scrap, India, the’s greatest economy, has consumed an excessive amount of time to enter the market. Not only is scrap production a big-buck making industry from car recycling, but it also coincides with the additional advantage of being environmentally sustainable by getting the old polluting cars off the roads. Nevertheless, it has become evident, despite the odd regulation, that India is firmly interested in making attempts to mitigate air pollution and preserve the environment. Related Books:- Products From Waste, Automobile, Leisure, Entertainment, Ware Housing & Real Estate Projects, Greases, Hospitality, Medical, Infrastructure, Lubricants, Petro Chemicals, Petroleum, Waste Management, Recycling Scrap Import in India Overview At 60.6 kg per capita, India's demand for steel is increasing, relative to over 400 kg per capita in developing countries. The need for steel is key to various urban/rural infrastructure projects implemented by the government and private sectors. The Indian steel sector contributes 50 percent of the share of secondary steel. As ferrous scrap is one of the major raw materials for secondary steel production units, India's steel scrap demand is around 16-18 mnt pa. Of this necessity, it imports around 1/3rd of the content. In India, scrap imports have seen a gradual rise in the last few years India's FY16 scrap supply stood at 6.2 mnt, a rise of 12.7% from 5.5 mnt of material imported in FY15. With the Make in India project eyeing 300 mnt steel capacity, raw material requirements are likely to expand. The inclusion of indigenous scrap from auto-shredding would place Indian producers in a position of benefit, considering the existing demand for scrap in India. In recent times, India witnessed its 18th bulk scrap shipments in 2016. The demand for raw materials is increasing gradually. Scrap Metal Recycling Business Possibility: Waste metals consist of many metals, with the exception of precious metals, such as iron, steel, copper, brass, aluminium, alloy, nickel, bronze, and many more. After multiple applications, such as in processing factories that produce utensils, frames, and various items utilizing these metals, these materials are left untouched as waste. Such metal waste arrives in big quantities and is very beneficial. Compared to some other recycling firm, what allows the metal recycling industry so much in popularity is the returns it provides. Related Books:- Waste Management, Waste Disposal And Recycling Industry You need to consider what you're going to recycle before you begin the business. To know precisely what is like to be in this market, it is therefore important to perform a viability study test. There are several benefits and drawbacks of this business, certain problems, and problems that fall in between that one wants to get an understanding about. Here's a short, thorough business strategy for metal recycling. What is needed to start the Business of Recycling? • Recycling plant: You need to have a factory which you build your recycling plant after deciding what kind of metal you are going to recycle and at what level. Consequently, since you recycle metal, you require an open area that is fairly large to construct the recycling facility, stock scrap metal, tools, machinery, and finished goods. Recycling metal is called a heavy industry task, so you must have a space-like warehouse. Projects: - Project Reports & Profiles • Infrastructure: To help your business, you ought to provide some decent infrastructure A locked area where the computers are going to work. The location in which you are going to bring your recycled products, the area where you are going to separate metals, disinfect them, and so on. You will need a vented room that suits a typical factory layout. Build the infrastructure for security concerns to the requirements of a factory. • Metal Scrap: Join forces with scrap pickers, scrap dealers, landowners, and their likes to have the sum of metal scrap needed. Test it with independent scrap laborers as they can supply you with the scrap at a very low rate relative to a regular scrap dealer. If the need is immense, you should approach wholesalers selling metal waste. • Equipment: You must have all the requisite recycling equipment, such as tanks, compressors, grinders, refiners, heating tools, etc. It would be safer if you got the new equipment since the modern equipment will be extremely efficient, and not traditional. Books:- BOOKS & DATABASES • Machinery Required: You ought to get the recycling system that is needed. There is usually no particular disposal machine for metal fragments since it is performed in separate phases. For instance, a separation machine, cleaner, melting machine, grinding machine, container forming, cooling field, etc. are needed. • Man Power: You do need human energy to function in your factory while being surrounded by so many robots. First, you ought to employ a specialist to guide your recycling venture since he would be well acquainted with the recycling work. You need any labor besides him, depending on the necessity. You will need to provide them with previous scrap metal plant experience. • Utilities: You require simple infrastructure like power link, water supply, transit system to convey recycled materials, better highways, plant at a required and chosen spot, and so on, much like every other plant. There could be other requirements that you might just have to look into in a scrap metal business cantered on the location wherever you want to operate your business. Market Research: - Market Research Report • Documents and permission: You are going to begin a company for metal recycling that can be further used by producers. You therefore ought to get licenses from various agencies. First of all, you ought to have a document for a metal recycling facility where you must even state which kind of material you are trying to reuse. Private Company Involvement Although MSTC's change is a positive step, it might not be a smart option to route every scrap supply into MSTC solely. Private sector engagement must be promoted. A combination of competition-based private and public sector employees would be more effective. Related Videos: - Business Ideas for Startups In the end, the automotive recycling industry in India portrays a tremendous opportunity for scrap production in the face of all the commitments and challenges. The use of scrap in steelmaking would lead to the steel cycle economy. India, as a developing world wants long-term opportunities to plug into such renewable, productive industries. India's Auto Shredding Kick Start-MSTC and Mahindra Intertrade JV In the freshly drafted MoU, MSTC Limited, a Mini Ratna Category-I PSU underneath the administrative jurisdiction of the Ministry of Steel, the Government of India, and Mahindra Intertrade Limited (MIL), combined forces to established India's first auto shredding factory. Related Videos:- Small Business Ideas The plant would be the first in the world to construct such auto shredding units in the series. In the Make in India initiative, India's foraying into the car shredding market is also a generation ahead. Can car recycling in India, become the next US, Europe, or China? The US, Europe, and China are the world's biggest and most mature auto-recycling industries. From as far back as the 1970s, as in the situation of the US, these nations have been destroying old cars. It is very well known that these are industries focused on waste and the justification for this is auto recycling. In the US, vehicle recycling dates back to the 1970s, while in the 2000s, Europe and Japan started recycling, followed by China in 2012. In developing countries, the overall industry value of car scraping is about 30+ million vehicles, producing about 27 million tonnes of waste. Vehicle Recycling Scope in India As India is the world's third-largest steelmaker, there is a tremendous opportunity for auto-recycling. India's car recycling will bring various advantages to the nation, ranging from a drive to fuel-saving and job growth in the automotive field. 25 percent (7 million vehicles) of the estimated cars that may originally be scrapped are projected to produce roughly USD 2.9 billion (analogous to ~INR 190 billion) in business. Such statistics are expected to rise with time. A car weights 1,400-1,600 kg on average. It contains 65-70% steel scrap, 7-8% aluminium scrap, 1-1.5% copper scrap and 15-20% rubber and plastic scrap upon recycle. A recycled car will earn approximately INR 30.000-35.000 at existing scrap rates (USD 380-455). It has the capacity to produce about 6 million tonnes (mnt) of waste, ~150,000 mt of copper scrap, ~0.8 mnt of aluminum scrap, and ~1.8 mnt of plastic and rubber scrap, considering 20-25% of vehicles are discarded in the first year. It is predicted that statistics will rise in the years ahead. Car Recycling Market Prospects In both the automobile and steel sectors, the car recycling market is a large sector with a strong market for End of Life Vehicles (ELV). The CEO of the Association of Automotive Recyclers (ARA), Michael E. Wilson, claims that both the prospects and the value of the automotive recycling market are increasing rapidly. These days, there are different opportunities for junk vehicle owners to sell their junk cars for money. On Craigslist, eBay and even directly to scrap yards and vehicle dealers, they will market their scrap vehicles. Scrap yards and car dealers bid at the very same time for EOL vehicles sold on Craigslist, eBay, or directly from holders of scrap cars. Businesses ought to guarantee that they are fitted with the newest equipment in the industry and meet ARA-specified requirements for auto reuse activities Voluntary scrapping of old cars is proposed by Union Budget 2021-22 It is focused on health tests for personal vehicles over 20 years and for commercial vehicles over 15 years. For the automotive industry that has been waiting for a 'Scrappage Scheme' for the past decade, this is a welcome change. Constructing every industry from zero is a challenging job, and before actually achieving profitability, it must forehead different obstacles. For every country, when an initiative of this size is hired to work, the position of its people is vital. Whereas the government can take this step to grow the business, the people of the country who want to make deliberate attempts to protect and preserve the ecosystem by giving up their old vehicles are still a major part of the obligation. Union Minister Nitin Gadkari said the strategy would contribute to approximately 10,000 crores of new investment and generate as many as 50,000 jobs. It is projected that such cars cause 10-12 times greater emissions than the new vehicles. Highlighting the policy's advantages, Gadkari said it would lead to scrap metal recycling, better protection, reduced air pollution, lower oil imports due to higher fuel consumption of existing vehicles, and encourage investment. Recycled content from old cars would further lower costs, adding that the turnover of the automotive sector, which is Rs. 4.5 lakh crore with exports of Rs. 1.45 lakh crore, will have a lift. Bottom Line The scrapping strategy would improve car purchases in the country as a fresh one will certainly be purchased by the one scrapping the vehicle. All in all, the Scrappage Program aims to help incorporate Rs 10,000 crore worth of fresh investment and generate 50,000 new employment options. The Scrappage Program would improve car purchases in the nation as a fresh one will definitely be purchased by the one scrapping the vehicle. Overall, with the green flagging off the “Scrappage Policy”, the business is likely to hike up in the coming days and the business investment is not going to let anyone down. Voluntary car scrapping scheme to drive out old and obsolete cars, not only helping to curb emissions, but also reducing the fuel import bills of India. All in, the Scrappage Program aims to help incorporate Rs 10,000 crore worth of fresh expenditure and add 50,000 new work prospects. NPCS is best known for providing a project report for its clients. All the project report covers detailed aspects of the business from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. You can get in touch with the NPCS team through the official website and get benefited from the books and project reports provided by us. Tags:- #AutomatedVehicleScrappingandRecycling #RecyclingUnit #AutomatedVehicle #AutomatedVehicleRecycling #WasteManagement #EwasteManagement #WasteManagementIndustry #WasteRecyclingBusiness #WasteManagementMarket #RecyclingUnitBusiness #AutomatedVehicleScrapping #InvestInStartups #StartupIndiaConsultants #Plan4Business #StartupPlan #StartupIdea #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #industrialproject #entrepreneurindia #startupbusiness #IndustrialWasteManagement
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Micronutrients Fertilizer

Micronutrient-efficient varieties grow deeper roots in mineral deficient soils and are better at tapping subsoil water and minerals. When topsoil dries, roots in the dry soil zone (which are the easiest to fertilizer) are largely deactivated and the plant must rely on deeper roots for further nutrition. The micronutrients are boron (B), copper (Cu), iron (Fe), manganese (Mn), molybdenum (Mo), zinc (Zn), and chloride (Cl). Micronutrient-efficient varieties grow deeper roots in mineral deficient soils and are better at tapping subsoil water and minerals. When topsoil dries, roots in the dry soil zone (which are the easiest to fertilizer) are largely deactivated and the plant must rely on deeper roots for further nutrition. Mixing micronutrients with fluid fertilizers has become a popular method of application. Clear liquids are commonly used as starter fertilizers for row crops and some micronutrients, especially zinc sources, are easily applied with these fluids. Micronutrient fertilizers can provide an optimal nutrient balance, tailored to the demands of the specific crop, soil and climate conditions Agriculture micronutrients are gaining popularity globally for obtaining better yield output. The global agriculture micronutrients market value is anticipated to increase from US$ 6,576.9 Mn in 2015 to US$ 13,344.2 MN by 2024, expanding at a CAGR of 8.3% during the forecast period (2016–2024). Increasing need for effective fertilizers due to poor soil quality and high demand for quality and uniform yield in view of the increasing population across the globe are factors anticipated to drive the growth of the agriculture micronutrients market over the forecast period. As a whole any entrepreneur can venture in this project without risk and earn profit. Few Indian major players • Abellon Agrisciences Ltd. • Agro Extracts Ltd. • Aries Agro Ltd. • Bayer Cropscience Ltd. • Champion Agro Ltd. • Coromandel Agro Products & Oils Ltd.
Plant capacity: Micronutrient Fertilizer for Fruit: 1,250 Kgs/Day Micronutrient Fertilizer for Vegetable: 750 Kgs/DayPlant & machinery: Rs.58 Lakhs
Working capital: -T.C.I: Cost of Project: 345 Lakhs
Return: 27.00%Break even: 55.00%
Add to Inquiry Add to Inquiry Basket

Oxygen and Nitrogen Gas Plant (Medical and Industrial Grade)

Limelight used oxygen derived from sources such as the barium oxide Brin process. This process was based on the production of barium peroxide by roasting barium oxide in air at 590°C, then raising the temperature to 870°C. At 870°C the peroxide formed decomposes back into oxide, releasing more or less pure oxygen which can then be cooled and compressed into steel gas cylinders. Although crude, the process was ingenious in that it required no continuous input of raw materials other than air and energy. Oxygen is non corrosive and can be contained in any common metals. However care must be taken to remove all oil, grease and other combustible material from piping and containers before putting them into oxygen service. Nitrogen gas is a compound that forms from elemental nitrogen, which is found abundantly throughout the planet’s atmosphere and in most biochemical reactions. One of nitrogen’s unique properties is its ability to form multiple bonds with various other elements and compounds. Nitrogen is the chemical element with the symbol N and atomic number 7. It was first discovered and isolated by Scottish physician Daniel Rutherford in 1772, nitrogen is the principal gas in air (78%). Its first major industrial use lay in the manufacture of ammonia, used within the chemical industry as an intermediate for many compounds but especially nitrogenous fertilisers. In the combustion process, the oxygen in air is broken down to make carbon dioxide, water, and energy. Nitrogen is not an essential part of the process. In fact, nitrogen in air has negative impacts on combustion processes. Nitrogen gets heated by the reaction to very high combustion temperatures and is carried out through the flue. Essentially, the heated nitrogen leaving the flue is like throwing fuel out of the stack. Nitrogen blanketing is used to protect flammable or explosive solids and liquids from contact with air. Certain chemicals, surfaces of solids and stored food products have properties that must be protected from degradation by the effects of atmospheric oxygen and moisture. Protection is achieved by keeping these items in a nitrogen atmosphere. India industrial gases market was valued at $ 2.1 billion in 2017 and is forecast to grow at a CAGR of over 11% to surpass $ 3.9 billion in 2023 on account of growing demand from metal industry, particularly steel. As a whole any entrepreneur can venture in this project without risk and earn profit. Few Indian major players • Air Liquide India Holding Pvt. Ltd. • Arrow Oxygen Ltd. • Bellary Oxygen Co. Pvt. Ltd. • Bhagawati Oxygen Ltd. • Bhilai Oxygen Ltd. • Govind Poy Oxygen Ltd. • Howrah Gases Ltd. • Linde India Ltd.
Plant capacity: 3200 cumtrs/DayPlant & machinery: Rs. 183 Lakhs
Working capital: -T.C.I: Cost of Project: Rs. 675 Lakhs
Return: 26.00%Break even: 50.00%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 21 of 63 | Total 630 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 21 62 63   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top